DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Furthers Baxter’s continued innovation in medication delivery and management Integrates Baxter’s decades of leadership in infusion therapy with innovative digital health solutions to build on the ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, announced new data from a retrospective study finding that machine ...

As predicted, not long after Baxter International issued an urgent safety communication about an issue with some of its Spectrum infusion pumps, it has been upgraded to a full-blown recall complete ...

Data suggest machine learning and artificial intelligence could help hospitals align drug libraries more closely to clinical practices, which may advance infusion safety Study conducted in partnership ...

After a drawn-out approval process, medical equipment company Baxter International received regulatory clearance for a new infusion pump machine that is expected to help the company capture more of ...

Baxter’s infusion pumps are in the crosshairs once again after cybersecurity software developer Rapid7 discovered multiple potential vulnerabilities in the devices. The Sigma Spectrum infusion pumps ...

To date, there have been no reports of serious injury associated with this issue. Baxter International has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump due to the ...

Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, announced new data from a retrospective study finding that machine learning, a type of artificial ...

In December 2025, Baxter International Inc. completed the final settlement of its cash tender offers, retiring all of its 2.600% senior unsecured notes due 2026 and purchasing a substantial portion of ...

Baxter International (BAX) has drawn fresh investor attention after recent trading, with the share price at $19.50 and mixed returns over the month and past 3 months prompting closer scrutiny of its ...